- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05903469
Implicit and Explicit Assessment of Suicide Risk (MIERIS)
May 23, 2025 updated by: Centre Hospitalier Universitaire, Amiens
In 2007 Nock & Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT).
This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence.
In 2020, the Poitiers team of Tello was able to replicate these results on a French population.
However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation.
The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt.
Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jérôme Thilliez, MD
- Phone Number: 03.22.66.82.90
- Email: thilliez.jerome@chu-amiens.fr
Study Locations
-
-
Picardie
-
Amiens, Picardie, France, 80000
- Recruiting
- Centre Hospitalier Universitaire D'Amiens
-
Contact:
- Jérôme Thilliez, MD
- Phone Number: 03.22.66.82.90
- Email: thilliez.jerome@chu-amiens.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Person presenting to emergencies for psychiatric reasons
- Adult person
- Free and informed consent signed
- Person speaking and writing French fluently
Exclusion Criteria:
- Neurological disorders or major cognitive deterioration: presence of confusion
- Acute psychotic decompensation
- Troubled acute behavior
- Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment
- Adult under protective measure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient with explicit suicidal ideation and suicide attempt
|
The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer.
The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.
|
|
Experimental: Patient with explicit suicidal ideation without suicide attempt
|
The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer.
The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.
|
|
Active Comparator: Patient without explicit suicidal ideation
|
The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer.
The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variation of IAT score betwenn the 3 groups
Time Frame: one year
|
IAT is Implicit Attitude Test The IAT is a brief computer-administered test that uses people's reaction times when classifying semantic stimuli to measure the automatic mental associations they hold about various topics, in this case, life and death/suicide.
The death/suicide IAT will be administered and scored in keeping with standard IAT procedures.
Response latencies for all trials were recorded and analyzed using the standard IAT scoring algorithm.
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 28, 2022
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
June 6, 2023
First Submitted That Met QC Criteria
June 6, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
May 29, 2025
Last Update Submitted That Met QC Criteria
May 23, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2020_843_0118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.